Last 12 months
Inside the activity.
0 purchase rows · 169 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 23 |
| Dec 2025 | 0 | 18 |
| Jan 2026 | 0 | 44 |
| Feb 2026 | 0 | 22 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 19 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2025 Filed Jun 4, 2025 21:36 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 1,860 | $71.50 | $132,990.00 |
DisclosureSEC source: 0001628280-25-029406 · wk-form4_1749073009.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,323 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 21:36 UTC |
Bonstein SaraChief Financial Officer
|
SaleCommon Stock | 1,579 | $71.50 | $112,898.50 |
DisclosureSEC source: 0001628280-25-029405 · wk-form4_1749072980.xml · nonDerivative · entry 1 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,288 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 20:42 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
SaleCommon Stock | 1,642 | $71.50 | $117,403.00 |
DisclosureSEC source: 0001628280-25-029372 · wk-form4_1749069723.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,579 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 20:40 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 5,472 | $71.50 | $391,248.00 |
DisclosureSEC source: 0001628280-25-029368 · wk-form4_1749069612.xml · nonDerivative · entry 5 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 308,758 F5 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 20:41 UTC |
MCGIRR DAVID W JDirector
|
SaleCommon Stock | 3,250 | $71.30 | $231,725.00 |
DisclosureSEC source: 0001628280-25-029370 · wk-form4_1749069680.xml · nonDerivative · entry 1 MCGIRR DAVID W J · CIK 0001219023 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,723 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 3,250 shares sold at prices ranging from $71.09 to $71.54 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:40 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,830 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001628280-25-029368 · wk-form4_1749069612.xml · derivative · entry 7 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 157,160 Underlying: Common Stock · 6,830 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:40 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 1,430 | $71.94 | $102,874.20 |
DisclosureSEC source: 0001628280-25-029368 · wk-form4_1749069612.xml · nonDerivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 233,924 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 1,430 shares sold at prices ranging from $71.67 to $72.24 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:40 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 4,400 | $71.35 | $313,940.00 |
DisclosureSEC source: 0001628280-25-029368 · wk-form4_1749069612.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 235,354 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 4,400 shares sold at prices ranging from $70.67 to $71.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:40 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 1,000 | $70.23 | $70,230.00 |
DisclosureSEC source: 0001628280-25-029368 · wk-form4_1749069612.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 239,754 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 1,000 shares sold at prices ranging from $69.59 to $70.57 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:40 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 6,830 | $10.85 | $74,105.50 |
DisclosureSEC source: 0001628280-25-029368 · wk-form4_1749069612.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 240,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:02 UTC |
Smith Michael AlexanderChief Legal Officer
|
SaleCommon Stock | 20,000 | $70.00 | $1,400,000.00 |
DisclosureSEC source: 0001628280-25-029012 · wk-form4_1748980929.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,045 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 20,000 shares sold at prices ranging from $70.00 to $70.04 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:02 UTC |
Smith Michael AlexanderChief Legal Officer
|
SaleCommon Stock | 6,327 | $68.56 | $433,779.12 |
DisclosureSEC source: 0001628280-25-029012 · wk-form4_1748980929.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,045 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 6,327 shares sold at prices ranging from $68.13 to $68.88 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 27, 2025 Filed May 29, 2025 20:46 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-028379 · wk-form4_1748551609.xml · nonDerivative · entry 1 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,616 Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:20 UTC |
Desjardins ClarissaDirector
|
PurchaseCommon Stock | 1,130 | $66.35 | $74,975.50 |
DisclosureSEC source: 0001628280-25-027340 · wk-form4_1747948827.xml · nonDerivative · entry 2 Desjardins Clarissa · CIK 0001793390 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 3,025 Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:22 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-027344 · wk-form4_1747948965.xml · nonDerivative · entry 5 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Melvin Sharoky C/F Wren J. Sharoky UTMA/FL Disclosed balance after: 100 F4 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Wren J. Sharoky UTMA/FL. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:22 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-027344 · wk-form4_1747948965.xml · nonDerivative · entry 4 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Melvin Sharoky C/F Leo J. Sharoky UTMA/FL Disclosed balance after: 100 F3 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Leo J. Sharoky UTMA/FL. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:22 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-027344 · wk-form4_1747948965.xml · nonDerivative · entry 3 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Melvin Sharoky C/F Violet A. Paley UTMA/FL Disclosed balance after: 100 F2 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Violet A. Paley UTMA/FL. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:22 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-027344 · wk-form4_1747948965.xml · nonDerivative · entry 2 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Melvin Sharoky C/F Owen F. Paley UTMA/FL Disclosed balance after: 100 F1 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Owen F. Paley UTMA/FL. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:22 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-027344 · wk-form4_1747948965.xml · nonDerivative · entry 1 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,816 Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:20 UTC |
Desjardins ClarissaDirector
|
PurchaseCommon Stock | 1,895 | $66.87 | $126,718.65 |
DisclosureSEC source: 0001628280-25-027340 · wk-form4_1747948827.xml · nonDerivative · entry 1 Desjardins Clarissa · CIK 0001793390 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 1,895 F1 · price: This is the weighted average purchase price representing 1,895 shares purchased at prices ranging from $66.75 to $66.98 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,830 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · derivative · entry 9 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 163,990 Underlying: Common Stock · 6,830 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 1,716 | $68.54 | $117,614.64 |
DisclosureSEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · nonDerivative · entry 7 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 233,924 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · price: This is the weighted average sales price representing 1,716 shares sold at prices ranging from $68.50 to $68.59 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 2,251 | $68.13 | $153,360.63 |
DisclosureSEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · nonDerivative · entry 6 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 235,640 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: This is the weighted average sales price representing 2,251 shares sold at prices ranging from $67.49 to $68.47 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 2,863 | $66.90 | $191,534.70 |
DisclosureSEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · nonDerivative · entry 5 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 237,891 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: This is the weighted average sales price representing 2,863 shares sold at prices ranging from $66.42 to $67.35 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 6,830 | $10.85 | $74,105.50 |
DisclosureSEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · nonDerivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 240,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 7,088 | $68.49 | $485,457.12 |
DisclosureSEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 314,230 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 7,088 shares sold at prices ranging from $68.38 to $68.59 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 4,480 | $67.96 | $304,460.80 |
DisclosureSEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 321,318 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 4,480 shares sold at prices ranging from $67.38 to $68.37 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 9,489 | $66.87 | $634,529.43 |
DisclosureSEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 325,798 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 9,489 shares sold at prices ranging from $66.34 to $67.32 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 16, 2025 Filed May 19, 2025 21:05 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 1,799 | $67.53 | $121,486.47 |
DisclosureSEC source: 0001628280-25-026581 · wk-form4_1747688735.xml · nonDerivative · entry 3 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,797 F3 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:06 UTC |
Bonstein SaraChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 31,610 | $0.00 Strike: $67.22 | $0.00 |
DisclosureSEC source: 0001628280-25-026586 · wk-form4_1747688783.xml · derivative · entry 2 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,610 Underlying: Common Stock · 31,610 shares Expires 2035-05-15 F3 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:06 UTC |
Bonstein SaraChief Financial Officer
|
GrantCommon Stock | 6,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-026586 · wk-form4_1747688783.xml · nonDerivative · entry 1 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,867 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:06 UTC |
Adsett RogerChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 31,610 | $0.00 Strike: $67.22 | $0.00 |
DisclosureSEC source: 0001628280-25-026585 · wk-form4_1747688771.xml · derivative · entry 2 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,610 Underlying: Common Stock · 31,610 shares Expires 2035-05-15 F3 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:06 UTC |
Adsett RogerChief Operating Officer
|
GrantCommon Stock | 6,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-026585 · wk-form4_1747688771.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,183 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:06 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantStock Option (right to buy) · Derivative | 27,100 | $0.00 Strike: $67.22 | $0.00 |
DisclosureSEC source: 0001628280-25-026584 · wk-form4_1747688760.xml · derivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,100 Underlying: Common Stock · 27,100 shares Expires 2035-05-15 F3 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:06 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantCommon Stock | 5,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-026584 · wk-form4_1747688760.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,221 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:05 UTC |
Lewis WilliamDirector · Chair and CEO
|
GrantStock Option (right to buy) · Derivative | 108,380 | $0.00 Strike: $67.22 | $0.00 |
DisclosureSEC source: 0001628280-25-026583 · wk-form4_1747688749.xml · derivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,380 Underlying: Common Stock · 108,380 shares Expires 2035-05-15 F3 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:05 UTC |
Lewis WilliamDirector · Chair and CEO
|
GrantCommon Stock | 22,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-026583 · wk-form4_1747688749.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,287 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:05 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 31,610 | $0.00 Strike: $67.22 | $0.00 |
DisclosureSEC source: 0001628280-25-026581 · wk-form4_1747688735.xml · derivative · entry 4 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,610 Underlying: Common Stock · 31,610 shares Expires 2035-05-15 F5 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:05 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 9,925 | $65.47 | $649,789.75 |
DisclosureSEC source: 0001628280-25-026581 · wk-form4_1747688735.xml · nonDerivative · entry 2 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,596 F3 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 9,925 shares sold at prices ranging from $65.32 to $65.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:05 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantCommon Stock | 6,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-026581 · wk-form4_1747688735.xml · nonDerivative · entry 1 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,521 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:05 UTC |
Smith Michael AlexanderChief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 27,100 | $0.00 Strike: $67.22 | $0.00 |
DisclosureSEC source: 0001628280-25-026580 · wk-form4_1747688723.xml · derivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,100 Underlying: Common Stock · 27,100 shares Expires 2035-05-15 F3 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:05 UTC |
Smith Michael AlexanderChief Legal Officer
|
GrantCommon Stock | 5,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-026580 · wk-form4_1747688723.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,372 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:57 UTC |
Brennan David RDirector
|
GrantCommon Stock | 5,058 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-026569 · wk-form4_1747688264.xml · nonDerivative · entry 1 Brennan David R · CIK 0001609305 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,933 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:57 UTC |
SCHAFER CAROLDirector
|
GrantCommon Stock | 5,058 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-026568 · wk-form4_1747688254.xml · nonDerivative · entry 1 SCHAFER CAROL · CIK 0001272181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,317 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:57 UTC |
Desjardins ClarissaDirector
|
GrantCommon Stock | 5,058 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-026567 · wk-form4_1747688244.xml · nonDerivative · entry 1 Desjardins Clarissa · CIK 0001793390 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,007 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:57 UTC |
SHAROKY MELVIN MDDirector
|
GrantCommon Stock | 5,058 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-026566 · wk-form4_1747688232.xml · nonDerivative · entry 1 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 301,216 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:57 UTC |
ANDERSON ELIZABETH MDirector
|
GrantCommon Stock | 5,058 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-026565 · wk-form4_1747688222.xml · nonDerivative · entry 1 ANDERSON ELIZABETH M · CIK 0001758247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,729 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:56 UTC |
MCGIRR DAVID W JDirector
|
GrantCommon Stock | 5,058 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-026564 · wk-form4_1747688210.xml · nonDerivative · entry 1 MCGIRR DAVID W J · CIK 0001219023 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,973 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:56 UTC |
LEE LEODirector
|
GrantCommon Stock | 5,058 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-026563 · wk-form4_1747688199.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,677 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 14, 2025 Filed May 15, 2025 20:36 UTC |
Smith Michael AlexanderChief Legal Officer
|
SaleCommon Stock | 409 | $65.61 | $26,834.49 |
DisclosureSEC source: 0001628280-25-025995 · wk-form4_1747341358.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,794 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.